Towards Prediction and Prevention of NIDDM
Seiten
1999
John Wiley & Sons Ltd (Verlag)
978-0-471-98595-2 (ISBN)
John Wiley & Sons Ltd (Verlag)
978-0-471-98595-2 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
This text focuses an area of considerable interest to both clinicians and researchers in diabetes, and presents a detailed introductory account of how NIDDM can be both predicted and prevented. It covers genetic markers, immune markers, cell markers, environmental factors and animal models.
This text focuses an area of considerable interest to both clinicians and researchers in diabetes, and presents a detailed introductory account of how NIDDM can be both predicted and prevented. It covers genetic markers, immune markers, cell markers, environmental factors and animal models, examines the cost-effectiveness of prevention strategies, and details many of the ethical aspects of screening and intervention.
This text focuses an area of considerable interest to both clinicians and researchers in diabetes, and presents a detailed introductory account of how NIDDM can be both predicted and prevented. It covers genetic markers, immune markers, cell markers, environmental factors and animal models, examines the cost-effectiveness of prevention strategies, and details many of the ethical aspects of screening and intervention.
Part I Introduction; Part II Genetics; Part III Other factors relevant to prediction; Pat IV Prevention; Part V Future development.
Erscheint lt. Verlag | 30.3.1999 |
---|---|
Reihe/Serie | Diabetes in Practice S. |
Zusatzinfo | index |
Verlagsort | Chichester |
Sprache | englisch |
Maße | 158 x 235 mm |
Gewicht | 710 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Diabetologie |
ISBN-10 | 0-471-98595-3 / 0471985953 |
ISBN-13 | 978-0-471-98595-2 / 9780471985952 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Vol. 1 & 2
Buch | Hardcover (2022)
McGraw-Hill Companies (Verlag)
229,99 €